 |
|
|
| |
A pilot study for safety and efficacy of 12 weeks sofosbuvir plus daclatasvir with or without ribavirin in egyptian adolescents with chronic hepatitis C virus Infection
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Manal El-Sayed* 1, Mohamed Hassany2, Noha Asem3
1Department of Pediatrics, Faculty of Medicine,Ain Shams University, 2Tropical Medicine Department , National Hepatology & Tropical Medicine Research Institute, 3Public Health Department , Faculty of Medicine , Cairo University, Cairo, Egypt
|
| |
|
|
|
|
|
